NBY icon

NovaBay Pharmaceuticals
NBY

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $354K invested in NovaBay Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

93% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 14

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$289K
2
+$9.36K
3
+$8.12K
4
Osaic Holdings
Osaic Holdings
Arizona
+$109

Top Sellers

1
-$121K
2
-$42K
3
-$21K
4
BCM
Bridgeway Capital Management
Texas
-$17K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$12.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$289K
2
$34K
3
$20.8K
4
$9.63K
5
$168
6
$168
7
$164
8
$41
9
$20
10
$20
11
$8
12
–
13
–
14
–
15
–
16
–
17
–
18
–
19
–
20
–
21
–
22
–
23
–
24
–
25
–